Wenyi Lu
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Iron Metabolism and Disorders
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Virus-based gene therapy research
Papers in
- Oncology 24
- CAR-T cell therapy research 20
- Hematology 14
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Mingfeng Zhao (40 shared papers)Xin Jin (20 shared papers)Xiaoyuan He (11 shared papers)Juanxia Meng (14 shared papers)Xia Xiao (18 shared papers)Rui Sun (9 shared papers)Juan Mu (10 shared papers)Xiao Chai (8 shared papers)
- Journals
- Frontiers in Immunology (5 papers)Blood (4 papers)Current Treatment Options in Oncology (3 papers)Frontiers in Oncology (3 papers)Cytotherapy (2 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Wenyi Lu
58 papers receiving 986 citations
Peers
Comparison fields: 5 of 75
- Hematology 292
- Genetics 181
- Oncology 366
- Immunology 153
- Environmental Chemistry 45
Countries citing papers authored by Wenyi Lu
This map shows the geographic impact of Wenyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Lu more than expected).
Fields of papers citing papers by Wenyi Lu
This network shows the impact of papers produced by Wenyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Lu. The network helps show where Wenyi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenyi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 114 | |
| 2 | 2015 | 112 | |
| 3 | 2013 | 77 | |
| 4 | 2020 | 50 | |
| 5 | 2021 | 50 | |
| 6 | 2019 | 50 | |
| 7 | 2018 | 49 | |
| 8 | 2020 | 40 | |
| 9 | 2023 | 40 | |
| 10 | 2017 | 32 | |
| 11 | 2017 | 31 | |
| 12 | 2020 | 23 | |
| 13 | 2019 | 22 | |
| 14 | 2023 | 21 | |
| 15 | 2023 | 20 | |
| 16 | 2023 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2013 | 16 | |
| 19 | 2022 | 15 | |
| 20 | 2019 | 15 |
About Wenyi Lu
Wenyi Lu is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Immunology, having authored 61 papers that have together received 997 indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Virus-based gene therapy research (9 papers), Acute Myeloid Leukemia Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Immune Cell Function and Interaction (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). The work is most often cited by research in Hematology (292 citations), Genetics (181 citations), Oncology (366 citations), Immunology (153 citations) and Environmental Chemistry (45 citations). Wenyi Lu has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Mingfeng Zhao, Xin Jin, Xiaoyuan He, Juanxia Meng, Xia Xiao, Rui Sun, Juan Mu, Xiao Chai, Cuicui Lyu and Lin Cheng. Their work appears in journals such as Frontiers in Immunology, Blood, Current Treatment Options in Oncology, Frontiers in Oncology and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.